Blood and Marrow Transplant (BMT) Services 

Saint Louis University Hospital offers a comprehensive inpatient and outpatient Blood and Marrow Transplant (BMT) program aimed at long-term remission or the cure of the patient’s disease. The BMT program provides an elevated standard of care that involves expert medical staff support, patient education and state of the art technology. Started in 1990, Saint Louis University Hospital, in conjunction with SLUCare physicians, have performed hundreds of blood and marrow transplants in patients from the United States, Canada and South America.

Since the fall of 2012, Saint Louis University Hospital has the first comprehensive outpatient blood, marrow and stem cell transplant center in the region, one of five centers in the nation. This is the only BMT center that can offer patients the option to receive their transplant predominantly in an outpatient setting, therefore avoiding a lengthy inpatient hospital stay. The center is located within the Saint Louis University Cancer Center on the hospital’s campus. Having the clinical expertise and facility to be able to offer this service enables the hospital and physicians to provide better care and often better outcomes for many transplant patients.

For more information about Saint Louis University Hospital's Center for Blood and Marrow Outpatient Transplant, visit

Our program is based on providing a multidisciplinary team approach to treating our patients. In addition to our specialty-trained medical oncologists, the team includes:

  • Dedicated BMT Nurse Practitioners
  • Oncology certified Nurse Coordinators
  • Oncology trained PharmD
  • Inpatient and outpatient Registered Nurses who are specialty trained in BMT and possess oncology and infusion certifications,
  • Master’s degree trained Social Workers
  • Pastoral Care
  • Physical Therapists
  • Dietitian
  • Insurance Coordinator specifically trained in transplant

Our program includes physicians who have trained and practiced around the U.S. and the world. Saint Louis University Hospital is fortunate to have these diverse backgrounds on our team because they have all brought different perspectives that have enhanced the clinical protocols and treatment planning of our program.

Our team performs BMT's for the following conditions:

  • AML, ALL, CML and CLL; MDS; Myelofibrosis and myeloproliferative disorders
  • Multiple myeloma / amyloidosis, Severe aplastic anemia
  • Hodgkin’s disease, NHL
  • Testicular
  • Renal cell, selected brain tumors and sarcomas

Autologous, allogeneic and syngeneic transplants are offered at Saint Louis University Hospital. The following are the types of allogeneic BMT’s that we offer:

  • Related: HLA (human leukocyte antigen) matched and mismatched
  • Unrelated: HLA matched and mismatched
  • Umbilical Cord Blood: Single and double; HLA matched and mismatched
  • Haploidentical

 Preparative Regimens include:

  • Myeloablative
  • Nonmyeloablative
  • Reduced intensity

Saint Louis University Hospital is committed to treating BMT patients with a comprehensive approach to care. The advantages of our BMT program include:

  • Team approach to care
  • Empowering the patient to take an active role while developing personalized treatment plans
  • Social, emotional and spiritual support along the entire continuum of care
  • Access to clinical trials including:
  • SWOG (Southwest Oncology Group)
  • SLU physician investigator trials
  • The oncology nursing floor consistently earns the ‘five star award’ for exceptional nursing care (this award is dependent on patient satisfaction surveys).

In addition to our own transplant patients, Saint Louis University Hospital assists in transplants around the world when we became an accredited National Marrow Donor Program (NMDP) Aphaeresis Center and Collection Center in 1993. Since this time, we have performed 197 donor collections on behalf of NMDP, helping to provide transplant products for national and international transplant facilities.

The BMT program at Saint Louis University Hospital is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) in all parts of transplant, including:

  • Collection Facility
  • Processing Facility
  • Clinical Program – Autologous Transplant
  • Clinical Program – Allogeneic Transplant